有価証券評価損益（△は益）、仕掛品、減損損失 - 医薬品他1件
- 【期間】
| 年度 | 有価証券評価損益（△は益） | 仕掛品 | 減損損失 - 医薬品 | 合計 |
|---|
| 2008/03 | - | | 7.57億 | | - | | 80.2億 | |
| 2009/03 | 82百万 | | 8.24億 | +8.9% | - | | 90.2億 | +12.5% |
| 2010/03 | - | | 8.64億 | +4.9% | - | | 101億 | +11.5% |
| 2011/03 | - | | 7.81億 | -9.6% | - | | 101億 | +0.8% |
| 2012/03 | - | | 7.75億 | -0.8% | - | | 101億 | +0% |
| 2013/03 | - | | 11.8億 | +52% | - | | 107億 | +5.4% |
| 2014/03 | - | | 12.7億 | +8% | - | | 119億 | +11.7% |
| 2015/03 | - | | 17.4億 | +36.5% | - | | 126億 | +5.8% |
| 2016/03 | - | | 20億 | +15% | - | | 138億 | +9.6% |
| 2017/03 | - | | 21.1億 | +5.5% | - | | 137億 | -0.9% |
| 2018/03 | - | | 26.1億 | +23.7% | - | | 132億 | -3.5% |
| 2019/03 | - | | 23.6億 | -9.4% | - | | 135億 | +1.7% |
| 2020/03 | - | | 22.7億 | -3.8% | 135億 | | 129億 | -3.9% |
| 2021/03 | - | | 24億 | +5.8% | - | | 115億 | -11% |
| 2022/03 | - | | 26.1億 | +8.7% | - | | 116億 | +1.2% |
| 2023/03 | - | | 27億 | +3.4% | - | | 123億 | +5.8% |
| 2024/03 | - | | 31.2億 | +15.6% | - | | - | |
